Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gray

Showing results (1411-1420 of 1,482) with videos related to

Pageof 149
Sort By:
Cell Reports|November 29, 2018
The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β ActivationJames E Vince, Dominic De Nardo, Wenqing Gao, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Plos One|August 4, 2009
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission areaMark E Polhemus, Shon A Remich, Bernhards R Ogutu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Nature Cell Biology|January 12, 2024
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriersRachel Joyce, Rosa Pascual, Luuk Heitink, et al.
Vaccine|April 19, 2016
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidateShawna F Graves, Bourema Kouriba, Issa Diarra, et al.
Annals of the American Thoracic Society|June 17, 2022
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic FibrosisSuzanne C Carter, Alessandro N Franciosi, Kate M O'Shea, et al.
NPJ Vaccines|April 27, 2022
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamstersGeorge Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Journal of Innate Immunity|March 18, 2016
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic FibrosisLaurent Meijer, Deborah J Nelson, Vladimir Riazanski, et al.
Pageof 149

Showing results (1411-1420 of 1,482) with videos related to

Sort By:
Pageof 149
Cell Reports|November 29, 2018
The Mitochondrial Apoptotic Effectors BAX/BAK Activate Caspase-3 and -7 to Trigger NLRP3 Inflammasome and Caspase-8 Driven IL-1β ActivationJames E Vince, Dominic De Nardo, Wenqing Gao, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 21, 2017
Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trialMay S ElSherif, Catherine Brown, Donna MacKinnon-Cameron, et al.
Plos One|August 4, 2009
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission areaMark E Polhemus, Shon A Remich, Bernhards R Ogutu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2020
Dual Targeting of CDK4/6 and BCL2 Pathways Augments Tumor Response in Estrogen Receptor-Positive Breast CancerJames R Whittle, François Vaillant, Elliot Surgenor, et al.
Nature Cell Biology|January 12, 2024
Identification of aberrant luminal progenitors and mTORC1 as a potential breast cancer prevention target in BRCA2 mutation carriersRachel Joyce, Rosa Pascual, Luuk Heitink, et al.
Vaccine|April 19, 2016
Strain-specific Plasmodium falciparum multifunctional CD4(+) T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidateShawna F Graves, Bourema Kouriba, Issa Diarra, et al.
Annals of the American Thoracic Society|June 17, 2022
Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic FibrosisSuzanne C Carter, Alessandro N Franciosi, Kate M O'Shea, et al.
NPJ Vaccines|April 27, 2022
Two DNA vaccines protect against severe disease and pathology due to SARS-CoV-2 in Syrian hamstersGeorge Giorgi Babuadze, Hugues Fausther-Bovendo, Marc-Antoine deLaVega, et al.
Cancer Discovery|December 6, 2018
Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic LeukemiaPiers Blombery, Mary Ann Anderson, Jia-Nan Gong, et al.
Journal of Innate Immunity|March 18, 2016
Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic FibrosisLaurent Meijer, Deborah J Nelson, Vladimir Riazanski, et al.
Pageof 149